Pera A - Search Results

1

Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M. Kohn A, et al. Among authors: pera a. Dig Liver Dis. 2002 Sep;34(9):626-30. doi: 10.1016/s1590-8658(02)80204-3. Dig Liver Dis. 2002. PMID: 12405248

2

Outcome of a conservative approach in severe ulcerative colitis.

Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A. Daperno M, et al. Among authors: pera a. Dig Liver Dis. 2004 Jan;36(1):21-8. doi: 10.1016/j.dld.2003.04.001. Dig Liver Dis. 2004. PMID: 14971812

3

Infliximab in the treatment of severe ulcerative colitis: a follow-up study.

Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M. Kohn A, et al. Among authors: pera a. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):235-7. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638237

4

The hazardous burden of Herpesviridae in inflammatory bowel disease: the case of refractory severe ulcerative colitis.

Lavagna A, Bergallo M, Daperno M, Sostegni R, Ravarino N, Crocellà L, Ramella A, Rocca R, Torchio B, Cavallo R, Pera A. Lavagna A, et al. Among authors: pera a. Dig Liver Dis. 2006 Dec;38(12):887-93. doi: 10.1016/j.dld.2006.07.011. Epub 2006 Aug 22. Dig Liver Dis. 2006. PMID: 16931197

5

The role of endoscopic assessment in ulcerative colitis in the era of infliximab.

Daperno M, Sostegni R, Pera A, Rognone D, Rigazio C, Ercole E, Crocellà L, Lavagna A, Rocca R. Daperno M, et al. Among authors: pera a. Dig Liver Dis. 2008 Jul;40 Suppl 2:S220-4. doi: 10.1016/S1590-8658(08)60529-0. Dig Liver Dis. 2008. PMID: 18598992 Review.

6

Infliximab and the risk of latent viruses reactivation in active Crohn's disease.

Lavagna A, Bergallo M, Daperno M, Sostegni R, Costa C, Leto R, Crocellà L, Molinaro G, Rocca R, Cavallo R, Pera A. Lavagna A, et al. Among authors: pera a. Inflamm Bowel Dis. 2007 Jul;13(7):896-902. doi: 10.1002/ibd.20131. Inflamm Bowel Dis. 2007. PMID: 17345605

7

Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker?

Sostegni R, Daperno M, Ercole E, Rigazio C, Bresso F, Masoero G, Castellino F, Zaffino C, Rocca R, Molinaro GC, Rocca G, Astegiano M, Pera A. Sostegni R, et al. Among authors: pera a. Dig Liver Dis. 2001 Dec;33(9):755-61. doi: 10.1016/s1590-8658(01)80692-7. Dig Liver Dis. 2001. PMID: 11838610

8

Review article: medical treatment of severe ulcerative colitis.

Daperno M, Sostegni R, Rocca R, Rigazio C, Scaglione N, Castellino F, Ercole E, Pera A. Daperno M, et al. Among authors: pera a. Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:7-12. doi: 10.1046/j.1365-2036.16.s4.2.x. Aliment Pharmacol Ther. 2002. PMID: 12047253 Review.

9

Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.

Paoluzi P, D'Albasio G, Pera A, Bianchi Porro G, Paoluzi OA, Pica R, Cottone M, Miglioli M, Prantera C, Sturniolo G, Ardizzone S. Paoluzi P, et al. Among authors: pera a. Dig Liver Dis. 2002 Nov;34(11):787-93. doi: 10.1016/s1590-8658(02)80072-x. Dig Liver Dis. 2002. PMID: 12546514 Clinical Trial.

10

Therapeutic ERCP in paediatric patients.

Rocca R, Castellino F, Daperno M, Masoero G, Sostegni R, Ercole E, Lavagna A, Barbera C, Canavese F, Pera A. Rocca R, et al. Among authors: pera a. Dig Liver Dis. 2005 May;37(5):357-62. doi: 10.1016/j.dld.2004.09.030. Dig Liver Dis. 2005. PMID: 15843086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters